Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
Cystic Fibrosis Patients Can Benefit from Vitamin Supplements, Research Shows Sep. 29, 2022 — Cystic fibrosis patients who supplement their diet with vitamin C can also derive greater benefit ...
Collaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate ...
Some people with cystic fibrosis still do not have access to the life-changing modulator therapy drugs, despite wider EMA ...
Young Minuteman Press franchise owner, Caroline Sweeney, has brought fresh energy and new potential to her Ashland based ...
Women are less likely to receive a lung transplant and spend an average of six weeks longer on the waiting list, according to ...
Sophie Pierce will be the first person with cystic fibrosis to attempt a 3,200-mile row across the Atlantic Ocean, travelling ...
The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...
Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction ...
The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...
K grant to accelerate development of Glox Therapeutics' novel precision antibiotics targeting AMR lung infections in people ...